Ma Xin

20,, 、,. 、. 、 “ ”.,.,, 、. 、 、. 、. 、 7. 、,.:.: 1. “ ” " " “ ” (2000) 2. “ ” “ ” (2002) 3. “ ” (2006) 4. “ ” (2006) 5. “ ” (2007) 6. “ - ” (2011) 7. “ ” (2012) 8. HEADPOST (2015) 9.: “ ” (2009): 2006:: SCI 6 ( 4 ), 50; 1, 11, 1.: 1. Ma X*, Ji XM, Fu P, Ding YC, Xue Q, Huang Y.Coexistence of High Fibrinogen and Low High-density Lipoprotein Cholesterol Levels Predicts Recurrent Cerebral Venous Thrombosis.Chin Med J (Engl). 2015,128(13):1732-7. doi: 10.4103/0366-6999.159345. 2. Dong J, Elmadhoun O, Ma X*. Aetiological diagnosis of middle-aged and elderly cryptogenic ischaemic cerebral vascular disease. Neurol Res. 2015,37(8):744-9. doi: 10.1179/1743132815Y.0000000056. 3. Dong J, Ma X*, Qie J, Ji X. Aortic Complex Plaque Predicts the Risk of Cryptogenic Ischemic Cerebrovascular Disease Recurrence. Aging and disease,2015, doi:10.14336/AD.2015.0923 4. Kong Q, Ma X*.Contributing Mechanisms of Aortic Atheroma in Ischemic Cerebrovascular Disease Journal of Stroke and Cerebrovascular Diseases,2015, doi:10.1016/j.jstrokecerebrovasdis.2015.09.033 5. Xue SF, Ma QF, Ma X, Jia J. P.Isolated Cortical Vein Thrombosis: A Widely Variable Clinicoradiological Spectrum. European neurology, 2013,69(6):331-335. 6. Ji RJ, Jia JP, Ma X, Wu Jn, Zhang YL, Xu LQ. Genetic Variants in the Promoter Region of the ALOX5AP Gene and Susceptibility of Ischemic Stroke. Cerebrovascular disease, 2011, 32(3):261-268. 7.,,,,,,,..,1998, 7:169-171. 8.,,..:,2000. 9.,,,,,,..,2005, 38:101-103. 10.,,,..,2005, 11:211-212. 11.,,,.TCD., 2005, 21:1036-1038. 12.,,,..